{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:32:45Z","timestamp":1793860365152,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.radonc.2021.02.020","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T16:36:54Z","timestamp":1614098214000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique"],"prefix":"10.1016","volume":"158","author":[{"given":"Emily","family":"Durie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Anthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ethell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Messiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-9762","authenticated-orcid":false,"given":"James","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-3562","authenticated-orcid":false,"given":"Gregory","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Westley","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Saran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6820-8578","authenticated-orcid":false,"given":"Henry C.","family":"Mandeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.02.020_b0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/COC.0b013e31826e0528","article-title":"American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI)","volume":"36","author":"Wolden","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.02.020_b0015","article-title":"Total body irradiation: a practical review","author":"Wills","year":"2016","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.radonc.2021.02.020_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0360-3016(95)02063-2","article-title":"Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation","volume":"34","author":"Ozsahin","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bmt.1702771","article-title":"Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes","volume":"27","author":"Chen","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2021.02.020_b0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-8140(91)90008-5","article-title":"Lung damage following bone marrow transplantation after hyperfractionated total body irradiation","volume":"22","author":"Latini","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.02.020_b0035","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2005.02.032","article-title":"Dose response and factors related to interstitial pneumonitis after bone marrow transplant","volume":"63","author":"Sampath","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/srep36730","article-title":"Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation","volume":"6","author":"Chiang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2021.02.020_b0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-104-2-168","article-title":"Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors","volume":"104","author":"Weiner","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2021.02.020_b0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2018.09.002","article-title":"Influence of total body irradiation dose rate on idiopathic pneumonia syndrome in acute leukemia patients undergoing allogeneic hematopoietic cell transplantation","volume":"103","author":"Gao","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijrobp.2015.10.054","article-title":"Factors influencing pulmonary toxicity in children undergoing allogeneic hematopoietic stem cell transplantation in the setting of total body irradiation-based myeloablative conditioning","volume":"94","author":"Abugideiri","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0360-3016(01)02589-5","article-title":"Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation","volume":"52","author":"Volpe","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0065","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bbmt.2009.05.016","article-title":"Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Abboud","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2021.02.020_b0070","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.bmt.1701022","article-title":"Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation","volume":"20","author":"Lawton","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2021.02.020_b0075","first-page":"3305","article-title":"Induction of severe cataract and late renal dysfunction following total body irradiation: dose-effect relationships","volume":"29","author":"Kal","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2021.02.020_b0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbmt.2005.12.029","article-title":"A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission","volume":"12","author":"Marks","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2021.02.020_b0085","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/1097-0142(20011001)92:7<1949::AID-CNCR1714>3.0.CO;2-1","article-title":"Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity","volume":"92","author":"Gopal","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.02.020_b0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/bmj.2.5966.336","article-title":"Royal College of Radiologists","volume":"2","author":"Ross","year":"1975","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2021.02.020_b0135","unstructured":"Royal College of Radiologists. Radiotherapy dose fractionation, 3rd ed. 2019: 66-67."},{"key":"10.1016\/j.radonc.2021.02.020_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tipsro.2019.05.002","article-title":"A step and shoot intensity modulated technique for total body irradiation","volume":"10","author":"Fog","year":"2019","journal-title":"Techn Innov Patient Supp Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.02.020_b0100","doi-asserted-by":"crossref","unstructured":"Report 83. Journal of the ICRU 2010;10:NP.1 \u2013 NP. https:\/\/doi.org\/10.1093\/jicru\/10.1.report83.","DOI":"10.1093\/jicru\/10.1.Report83"},{"key":"10.1016\/j.radonc.2021.02.020_b0105","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0360-3016(83)90393-0","article-title":"Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation","volume":"9","author":"Barrett","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0110","article-title":"A double-headed CO-60 unit for large-field irradiation","volume":"61","author":"Lewis","year":"1988","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.02.020_b0115","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0360-3016(02)03039-0","article-title":"Renal toxicity after total body irradiation","volume":"54","author":"Borg","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.020_b0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.radonc.2021.02.020_b0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajh.20648","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Nakamae","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.radonc.2021.02.020_b0130","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","author":"Kdigo Work Group","year":"2013","journal-title":"Kidney Int Suppl"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:15:09Z","timestamp":1759122909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021060837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":27,"alternative-id":["S0167814021060837"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.02.020","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}